Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Transforming growth factor-β-mediated signaling in T lymphocytes impacts on prostate-specific immunity and early prostate tumor progression
Kerrilyn R. Diener, Anthony E. Woods, Jim Manavis, et al.
Laboratory Investigation (2008) Vol. 89, Iss. 2, pp. 142-151
Open Access | Times Cited: 17

Showing 17 citing articles:

Ipilimumab versus placebo after radiotherapy in patients with metastatic castration-resistant prostate cancer that had progressed after docetaxel chemotherapy (CA184-043): a multicentre, randomised, double-blind, phase 3 trial
Eugene D. Kwon, Charles G. Drake, H. I. Scher, et al.
The Lancet Oncology (2014) Vol. 15, Iss. 7, pp. 700-712
Open Access | Times Cited: 1406
The dynamic roles of TGF‐β in cancer
Erik Meulmeester, Peter ten Dijke
The Journal of Pathology (2010) Vol. 223, Iss. 2, pp. 206-219
Open Access | Times Cited: 373
Tumor infiltrating B-cells are increased in prostate cancer tissue
Jason Woo, Michael A. Liss, Michelle Muldong, et al.
Journal of Translational Medicine (2014) Vol. 12, Iss. 1
Open Access | Times Cited: 167
Artesunate down-regulates immunosuppression from colorectal cancer Colon26 and RKO cells in vitro by decreasing transforming growth factor β1 and interleukin-10
Cheng Cui, Helin Feng, Xinli Shi, et al.
International Immunopharmacology (2015) Vol. 27, Iss. 1, pp. 110-121
Closed Access | Times Cited: 37
Chemotherapy and immunotherapy combination in advanced prostate cancer.
Susan F. Slovin
PubMed (2012) Vol. 10, Iss. 2, pp. 90-100
Closed Access | Times Cited: 37
An immunogenic phenotype in paternal antigen‐specific CD8+ T cells at embryo implantation elicits later fetal loss in mice
Lachlan M. Moldenhauer, Kerrilyn R. Diener, John D. Hayball, et al.
Immunology and Cell Biology (2017) Vol. 95, Iss. 8, pp. 705-715
Closed Access | Times Cited: 30
Bisphenol A Disrupts HNF4α-Regulated Gene Networks Linking to Prostate Preneoplasia and Immune Disruption in Noble Rats
Hung‐Ming Lam, Shuk‐Mei Ho, Jing Chen, et al.
Endocrinology (2015) Vol. 157, Iss. 1, pp. 207-219
Open Access | Times Cited: 24
Cell-Intrinsic Abrogation of TGF-β Signaling Delays but Does Not Prevent Dysfunction of Self/Tumor-Specific CD8 T Cells in a Murine Model of Autochthonous Prostate Cancer
Cassie Chou, Andrea Schietinger, H. Denny Liggitt, et al.
The Journal of Immunology (2012) Vol. 189, Iss. 8, pp. 3936-3946
Open Access | Times Cited: 24
TGF-β signalling and immunity in prostate tumourigenesis
Kerrilyn R. Diener, Eleanor F. Need, Grant Buchanan, et al.
Expert Opinion on Therapeutic Targets (2010) Vol. 14, Iss. 2, pp. 179-192
Closed Access | Times Cited: 23
Prostate cancer, tumor immunity and a renewed sense of optimism in immunotherapy
Nicolò Rigamonti, Matteo Bellone
Cancer Immunology Immunotherapy (2012) Vol. 61, Iss. 4, pp. 453-468
Open Access | Times Cited: 21
Treatment combining RU486 and Ad5IL-12 vector attenuates the growth of experimentally formed prostate tumors and induces changes in the sentinel lymph nodes of mice
Claudia Raja Gabaglia, Alexandra DeLaney, Jennifer M. Gee, et al.
Journal of Translational Medicine (2010) Vol. 8, Iss. 1
Open Access | Times Cited: 13
Is there a role for immune checkpoint blockade with ipilimumab in prostate cancer?
Edward Cha, Eric J. Small
Cancer Medicine (2013) Vol. 2, Iss. 2, pp. 243-252
Open Access | Times Cited: 12
Toward Maximizing Immunotherapy in Metastatic Castration-Resistant Prostate Cancer – Rationale for Combinatorial Approaches Using Chemotherapy
Susan Slovin
Frontiers in Oncology (2012) Vol. 2
Open Access | Times Cited: 10
Fine needle aspiration of metastatic prostate carcinoma simulating a primary adrenal cortical neoplasm: A case report and review of the literature
Andrea P. Subhawong, Ty K. Subhawong, Qing Kay Li
Diagnostic Cytopathology (2009) Vol. 38, Iss. 2, pp. 147-153
Closed Access | Times Cited: 9
Is the Genetic Background of Co-Stimulatory CD28/CTLA-4 Pathway the Risk Factor for Prostate Cancer?
Lidia Karabon, Krzysztof Tupikowski, Anna Tomkiewicz, et al.
Pathology & Oncology Research (2017) Vol. 23, Iss. 4, pp. 837-843
Closed Access | Times Cited: 6
Immunotherapy and cancer – making the past prologue
Susan F. Slovin
Clinical Investigation (2012) Vol. 2, Iss. 9, pp. 873-881
Closed Access
Page 1

Scroll to top